Seeing Is Believing
VRCA is currently covered by 5 analysts with an average price target of $13.99. This is a potential upside of $7.2 (106.04%) from yesterday's end of day stock price of $6.79.
Verrica Pharmaceuticals's activity chart (see below) currently has 34 price targets and 39 ratings on display. The stock rating distribution of VRCA is 15.79% HOLD and 84.21% BUY.
Analysts average stock forecasts to be materialized ratio is 8.21% with an average time for these price targets to be met of 58.71 days.
Highest price target for VRCA is $14, Lowest price target is $8, average price target is $13.99.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 01-Mar-2024. First documented stock forecast 21-Feb-2019.
Currently out of the existing stock ratings of VRCA, 3 are a HOLD (15.79%), 16 are a BUY (84.21%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$1.21 (17.82%)
8
1 months 24 days ago
1/8 (12.5%)
$2.45 (44.14%)
253
Buy
13
$6.21 (91.46%)
12
1 months 24 days ago
0/12 (0%)
$7.45 (134.23%)
Buy
10
$3.21 (47.28%)
10
4 months 10 days ago
0/2 (0%)
$3.91 (64.20%)
Buy
14
$7.21 (106.19%)
4
9 months ago
1/4 (25%)
$8.68 (163.16%)
79
Buy
14
$7.21 (106.19%)
11
9 months ago
1/5 (20%)
$8.68 (163.16%)
79
What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?